Benefits of Genetic Technologies in Agricultural, Medical and Industrial Uses

Q1 — Sample Band 6 response (8 marks), annotated

A "benefit" of a genetic technology is only meaningful when it is named for a specific domain, compared with a specific alternative, and identified for a specific affected party. Generic claims that the technology "helps people" do not count as evaluation. [1 — defines a benefit in domain / comparison / party terms]

In agriculture, genetic technologies can deliver yield, resistance and nutritional benefits. Bt cotton, which expresses a Bacillus thuringiensis Cry-toxin gene, has raised lint yield by roughly 27% in pooled Australian and Indian trials while cutting insecticide sprays by about 74% — a clear resistance-trait benefit to growers compared with conventional cultivars. Golden Rice expresses two transgenes that produce β-carotene in the endosperm, illustrating nutritional modification as a different agricultural benefit aimed at consumers in vitamin-A-deficient populations. [1 — agricultural benefit with named example(s)]

In medicine, genetic technologies have shifted insulin production from animal pancreases (pig/cow) to recombinant E. coli and yeast host cells, supplying essentially the entire global insulin market by the mid-2010s. Recombinant hepatitis B vaccine produced in yeast has supported global childhood immunisation. These are medical benefits — controlled biological systems producing useful proteins reliably and at scale, with structural identity to the human protein. [1 — medical benefit with named example]

In industry, engineered Trichoderma reesei produces cellulase enzymes at roughly 20× higher titre than the wild-type strain, dropping enzyme cost per litre of second-generation bioethanol by an order of magnitude. Engineered Aspergillus niger produces chymosin (rennin) for cheese manufacture, replacing calf rennet. These are industrial benefits — biological manufacturing at scale, with consistency that older processes could not match. [1 — industrial benefit with named example]

However, agricultural benefit is not the same as biodiversity benefit. Bt cotton, Roundup Ready soybean, Cavendish bananas and similar systems concentrate production on a narrow range of high-performing genotypes. This selects strongly on pests (e.g. rising bollworm resistance to Cry-toxins) and reduces on-farm crop genetic diversity, lowering resilience to new diseases, climate stress or pesticide failure. The medical and industrial domains do not have this trade-off in the same form because their "host" is a contained fermenter, not a landscape. [1 — biodiversity trade-off named and located in agriculture only]

Strong HSC evaluation reflects this asymmetry. In medicine and industry the case for benefit is comparatively clean: outcomes are measurable, comparators are explicit (animal-sourced insulin; chemical synthesis; fossil-fuel processing), and trade-offs are mostly access/cost rather than ecological. In agriculture the case is more conditional because biodiversity must be held in view alongside productivity. [1 — domain-aware contrast between agriculture and medicine/industry]

Therefore genetic technologies can be highly beneficial, but the type and extent of benefit depends on the application. They are most defensible where the domain has explicit comparators (medical proteins replacing animal-sourced products; industrial enzymes replacing high-energy chemical processes) and most contested where ecological trade-offs are real (agricultural monocultures narrowing biodiversity). The strongest judgement preserves both halves of that picture rather than collapsing it into a slogan. [1 — conditional judgement using lesson terminology] [1 — overall coherence and HSC register]

Marking criteria.

• 1 mark — Defines what counts as a benefit (domain, comparison, affected party) rather than treating "beneficial" as self-evident.
• 1 mark — Names at least one specific agricultural benefit with a real example (Bt cotton, Golden Rice, Roundup Ready, etc.).
• 1 mark — Names at least one specific medical benefit with a real example (recombinant insulin, hepatitis B vaccine antigen, Factor VIII, etc.).
• 1 mark — Names at least one specific industrial benefit with a real example (cellulase, chymosin, subtilisin protease, etc.).
• 1 mark — Identifies the biodiversity trade-off and locates it specifically in agriculture, with mechanism (narrow range of genotypes / monoculture / selection for resistance).
• 1 mark — Explicitly contrasts the agricultural domain (ecological trade-off) with medicine/industry (mostly access/cost trade-offs in contained systems).
• 1 mark — Reaches a domain-aware, conditional judgement using lesson terminology ("can be highly beneficial", "depends on the application", "must be weighed against").
• 1 mark — Sustained HSC register: coherent paragraphing, precise vocabulary, no one-sided slogans.

Q2 — Sample Band 6 response (7 marks), annotated

Golden Rice fits under nutritional modification in Card 2 — its purpose is to improve the nutritional profile of an existing staple crop (rice) rather than to increase yield or pest resistance. The β-carotene precursor of vitamin A accumulates in the endosperm because two transgenes drive carotenoid biosynthesis in tissue that normally lacks it. [1 — correct benefit category identified with mechanism]

The benefit is real for a specific affected party: children in regions with chronic vitamin A deficiency, where rice is the dominant staple and other vitamin-A sources are inaccessible. The relevant comparison is not "a perfect diet" but the realistic alternative — pure white rice in a deficient diet, supplemented (if at all) by fortification programs that have historically struggled to reach rural populations at scale. Against that comparator Golden Rice provides a measurable per-meal contribution to vitamin-A intake. [1 — domain, comparison and affected party explicitly named]

However, Card 5 reminds us that agricultural benefit and biodiversity benefit are not the same. If Golden Rice adoption displaces traditional Asian rice landraces — many of which carry locally adapted alleles for disease resistance, salinity tolerance and flavour preferences — then on-farm genetic diversity narrows, and long-term resilience can fall. The narrower the genetic base of staple rice, the higher the risk that a single new pathogen or environmental change has a population-wide effect (as the Cavendish banana case illustrated for vegetative crops). [1 — biodiversity trade-off applied with mechanism] [1 — links to broader Card 5 framework, not just stimulus]

Strong evaluation refuses to collapse this into yes/no. Golden Rice can be a defensible agricultural benefit because the nutritional gain to vitamin-A-deficient children is real, but its long-term value depends on whether national programs accompany its release with seed-saving, landrace conservation and farmer choice — i.e. whether biodiversity is maintained alongside the new cultivar. [1 — conditional reasoning, not a verdict]

Therefore a defensible recommendation is conditional release: approve Golden Rice as one option within a portfolio that preserves landraces and continues fortification and dietary diversification, rather than replacing existing varieties wholesale. This applies Card 5's "strong judgement style" — state the benefit clearly, name the biodiversity risk clearly, and conclude in conditional language. [1 — Card-5 high-yield wording applied] [1 — coherent recommendation in HSC register]

Marking criteria.

• 1 mark — Identifies Golden Rice as nutritional modification (Card 2 category) and names the biological mechanism (β-carotene accumulation in endosperm).
• 1 mark — Names the realistic comparator (rice-dominant deficient diet / under-performing fortification) and the affected party (vitamin-A-deficient populations).
• 1 mark — Identifies the specific biodiversity trade-off (displacement of locally adapted landraces, loss of adaptive alleles).
• 1 mark — Connects this trade-off to a general Card 5 / Card 4 principle (narrow genotypes → reduced resilience), not just the stimulus.
• 1 mark — Maintains conditional reasoning ("benefit depends on whether…") rather than declaring a winner.
• 1 mark — Reaches a justified recommendation that pairs Golden Rice with biodiversity-preserving practices.
• 1 mark — Uses precise lesson terminology (nutritional modification, biodiversity trade-off, narrow range of genotypes, conditional language).

Q3 — Sample Band 6 response (6 marks)

The claim is partly correct but largely flawed. [1 — judgement]

What is defensible: Genetic technologies can improve productivity in agriculture, and they do deliver genuine domain-specific benefits — Bt cotton's yield gains, recombinant insulin's global supply, engineered cellulase in biofuel manufacture. The technology is not a fraud or a fringe issue. [1 — concedes the correct element]

What is wrong:

• "No real downside worth mentioning." Card 5 directly contradicts this. Agricultural biotechnology can narrow the range of genotypes used at scale (e.g. monocultures of Bt cotton or Roundup Ready soy), select for resistant pests, and reduce resilience to new stressors. Excluding this from an evaluation is precisely the Band-3 trap flagged in the Card 1 exam-trap callout. [1 — refutes "no downside" with biodiversity mechanism]
• "Improves productivity" treated as the whole benefit. The lesson explicitly warns against collapsing all benefits to efficiency. Medical benefits are about useful protein production and treatment support; industrial benefits are about scale and consistency of biological manufacturing. Productivity alone misses two-thirds of the picture. [1 — refutes "productivity = benefit"]
• "Anyone raising biodiversity concerns is standing in the way of progress." This is the slogan move that Card 1 explicitly rejects. Biodiversity concerns are part of strong evaluation, not opposition to it; treating concern as obstruction is precisely the rhetorical failure the lesson trains students out of. [1 — refutes the dismissal of biodiversity concerns]

Defensible reformulation: "Genetic technologies can be highly beneficial — Bt cotton has raised cotton yields and cut insecticide use, recombinant insulin has replaced animal-sourced insulin globally, and engineered cellulase has made second-generation biofuels viable. However, agricultural benefits in particular must be weighed against biodiversity trade-offs, because reliance on a narrow range of genotypes can reduce resilience. The overall judgement is therefore conditional: the technology delivers real domain-specific benefits, but those benefits must be evaluated against domain-specific trade-offs rather than asserted as obvious." [1 — biologically defensible reformulation with named example and conditional language]

Marking criteria.

• 1 mark — Overall evaluative judgement of the claim (partly correct but largely flawed).
• 1 mark — Correctly concedes the defensible element (real domain-specific benefits exist).
• 1 mark — Correctly refutes "no real downside" using the biodiversity / narrow-genotype mechanism.
• 1 mark — Correctly refutes "productivity = benefit" by citing medical and industrial benefit types.
• 1 mark — Correctly refutes the rhetorical dismissal of biodiversity concerns (Card 1 exam-trap).
• 1 mark — Reformulates the claim into a defensible Band-5 statement using a named example, domain language and conditional / balanced phrasing.